The expression profiles suggest that the H19/LincRNA H19/miR-675/MRP3-HOXA1-MMP16 axis contributes to the initiation and progression of breast cancer, highlighting potential targets for therapeutic strategies (refer to Figure 1). Here, MMP16 is linked to breast cancer.